Transmitted drug resistance in French HIV-2-infected patients-Reference-Cited by-同舟云学术

Transmitted drug resistance in French HIV-2-infected patients

Published:2013-06-19 Issue:10 Volume:27 Page:1671-1674
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Charpentier Charlotte,Visseaux Benoit,Bénard Antoine,Peytavin Gilles,Damond Florence,Roy Céline,Taieb Audrey,Chêne Geneviève,Matheron Sophie,Brun-Vézinet Françoise,Descamps Diane

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference17 articles.

1. 20 years of HIV-2 infection in Portugal: trends and changes in epidemiology.;Valadas;Clin Infect Dis,2009

2. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 20062007 in France.;Descamps;J Antimicrob Chemother,2010

3. Transmitted antiretroviral drug resistance in New York state, 2006-2008: results from a new surveillance system.;Readhead;PLoS One,2012

4. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.;Hamers;Lancet Infect Dis,2011

5. Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda.;Eshleman;AIDS,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British HIV Association guidelines for the management of HIV‐2 2021;HIV Medicine;2021-12

2. Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions;Aids Reviews;2021-03-24

3. Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease;Molecules;2021-01-25

4. Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease;BMC Molecular and Cell Biology;2020-06-23

5. Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe;Clinical Infectious Diseases;2020-03-30